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Myth #4: The use of digital subtraction imaging during
lumbar TFESI correctly identifies intra-arterial uptake and
allows prevention of neurological events in all cases.
Fact: The proper implementation and interpretation of
digital subtraction imaging are operator dependent and
do not inherently prevent an intra-arterial injection during lumbar transforaminal epidural steroid injection.
A case of spinal cord infarction with resulting paraplegia has been reported in association with a lumbar TFESI
in which DSI was used. This case report illustrates that
use of DSI does not guarantee safety, as the correct implementation and interpretation of DSI images depends

on operator skills and experience. The appropriate use of
DSI includes the following steps:
1. Instruct the patient to hold their breath, not speak, and remain
still during the several second DSI run.
2. Obtain a blank mask image (i.e., no observable bony
projections).
3. Inject contrast and observe the flow pattern in a wide AP view.
4. Inject an adequate volume of contrast medium to provide confidence of epidural spread without concomitant fill of a radiculomedullary artery or other blood vessels.

It must be acknowledged that there is insufficient published evidence to determine if intra-arterial injection can
be ruled out by DSI in every case even when these technical factors are optimized by an operator who is also experienced in the interpretation of the images acquired. As
such, it remains important to use dexamethasone as the
firstline agent for lumbar TFESIs, even when live DSI is
used.
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Dear Editor,
Project ECHO Chronic Pain is a telehealth intervention hosted by Weitzman Institute at Community Health
Center, Inc. (CHCI), in Middletown, Connecticut, a large

federally qualified health center. Designed to help primary care providers (PCPs) treat patients with chronic
pain, Project ECHO Chronic Pain uses a videoconference
platform to offer a 10-month series of twice-monthly
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inadvertent intra-arterial injection of local anesthetic
would cause temporary lower extremity weakness that
warns the physician of unintended needle tip position
before injection of a particulate steroid that, if injected
into this artery, could cause neurologic infarction.
However, given the evidence for the safety of dexamethasone use in TFESI, the use of an anesthetic test dose is
likely unnecessary. In fact, a test dose of local anesthetic
could cause temporary motor block, which might increase the possibility of a fall postinjection, thus decreasing the overall safety of this procedure. If particulate
steroid is injected, the potential benefit of the test dose
may outweigh the risks associated with these side effects.
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Table 1. Count of 320 recommendations consistent with the
CDC guidelines
Category/
Recommendation Recommendation
Consider nonpharmacologic therapy and
nonopioid pharmacologic therapy first or
in combination with opioid therapy.
Establish treatment goals with patients
Discuss with patients known risks and realistic benefits of opioid therapy and patient
and clinician responsibilities
Opioid selection, dosage, duration, followup, and discontinuation
Assessing risk and addressing harms of opioid use

194

CDC
Category

Explanation of CDC
Guideline

Examples of Quotes from
Transcribed
Recommendations

Category 1/Subcategory A

Category 1/A Consider nonpharmaco- Get her into physical therapy
logic therapy and nonand follow up after three
opioid pharmacologic
visits to ask if it is working.
therapy first or in com- Might be worth getting a
bination with opioid
family counseling session
therapy.
with a family therapist.
Can use Lyrica to replace
gabapentin if gabapentin
doesn’t work.
Category 1/B Establish treatment goals If she wants to keep taking
with patients.
tramadol, tie it to a functional goal like “I want to
be able to specifically do
this one thing I can’t do
without it.”
Ask the patient to tell you his
functional goals and work
toward getting him some
small successes.
Category 1/C Discuss with patients
Explain to the patient about
known risks and realishow the oxycodone is
tic benefits of opioid
working as an anti-anxiety
therapy and patient
for her and that treating her
and clinician
anxiety with other things
responsibilities.
like Lexapro would be
better.
Tell him: I don’t know
enough about you to give
you opioids and have it be
safe for you.
Category 2
Opioid selection, dosage, Once you get below the 100
micrograms of fentanyl
duration, follow-up,
[patch], you can go to 72
and discontinuation
[mcg] every 48 [hours] or
change the interval. When
you get down to tiny doses,
start to lengthen the
interval.
Get her off the oxycodone
more quickly. You could do
it over a month.
The drop in the morphine is
too fast for chronic pain.
We send out any urine
Category 3
Assessing risk and
screens for the drug they
addressing harms of
opioid use
are taking regardless of risk
level.
He’s at really high risk for diverting some of this opioid.
If you are concerned about
suicidality, work down on
number of tablets. Anxiety
will probably go up as
Percocets go down!

This was the largest category, with 194 recommendations.
Expert faculty recommended physical therapy (12); occupational therapy (7); behavioral health interventions, such
as further evaluation, professional treatment, and community support groups (62); nonopioid medications such as
nonsteroidal anti-inflammatory drugs and topical

applications (12), anticonvulsants (15), and antidepressants (25); complementary medicine (15); lifestyle changes,
such as diet and exercise (34); and evaluation by a pain

Category 1/B
Category 1/C

Category 2
Category 3

18
30

49
29

two-hour interactive sessions. During each session, PCPs
present two to four patient cases to a multidisciplinary
faculty of experts from the Integrative Pain Center of
Arizona in Tucson, who offer recommendations for pain
management.
Our institutional review board–approved study asked
if the expert faculty’s recommendations were consistent
with the CDC Guidelines for Prescribing Opioids for
Chronic Pain [1]. We randomly chose 25 of 67 cases presented during a 10-month series from April 2016 through
November 2016; 179 PCPs from 82 practices in 14 states
attended at least one session. Recommendations were
transcribed, yielding 406 discrete units of data. Two
researchers analyzed the data using the CDC guidelines
as a priori coding categories for a text-driven deductive
approach to content analysis [2,3]. The researchers discussed the assignment of data to the categories, in consultation with a third researcher, until there was mutual
agreement on the content of the categories.
The content analysis found that 79% (320) of the 406
units of data could be assigned to specific CDC guidelines
(Table 1). The remaining data addressed other issues, for
example, how to assess the patient by tapping along a
scar, imaging or other tests, comorbid conditions such as
diabetes, and behavioral health. In Table 1, Category 1
of the guidelines—“Determining when to Initiate or
Continue Opioids for Chronic Pain”—was broken down
into three subcategories (A, B, C) for analysis. Categories
2 and 3—“Opioid Selection” and “Assessing Risk”—
were not broken down further. Table 2 lists examples of
quotes for each category.
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•
•

•

Tell him he can’t get opiates unless he goes to behavioral health.
Developmental history puts him at high risk of poor outcome for
physical treatment [medications, physical therapy], so treat mental health first.
Address his weight [less back pain if he loses weight].

Another 27 recommendations related to assessment,
management, and mitigation of risk were couched in psychosocial terms:
•
•

You can’t continue prescribing opioids if her boyfriend keeps
stealing them.
Maybe switch to a long-acting alprazolam because of the
[reduced risk of] overdose and worry about selling.

Three recommendations addressed extrinsic issues:
•

It is legitimate for him to be on eight-hour dosing for
OxyContin, but insurance won’t cover eight-hour dosing, only
12-hour dosing.

The expert faculty encouraged providers to address
confounding psychosocial risk factors directly, as they can
increase vulnerability to misuse of opioids and make
engagement with a treatment plan more difficult 4,5. For
example, a more thorough assessment of patients’ developmental history and behavioral health might reveal unresolved emotional trauma, a family history of addiction,
behavioral health disorders, and so on. Also, providers
should better understand the patients’ social determinants
of health, such as living conditions, education and health literacy, access to community resources, etc.
Once risk factors are better understood, the patient
must engage with the provider in a treatment plan built
on a supportive relationship and mutual understanding
of treatment goals. The approach recommended by the
faculty can be described as “carrot and stick.” On one
hand, explaining how opioids are not effective in pain
management, providing positive reinforcement for what
patients are doing right, and encouraging them to better
care for themselves help keep patients engaged. Providers
might build a bridge to decreasing reliance on opioids by
combining nonopioid medications with other treatments
first. On the other hand, providers can make treatment
with opioids contingent on a patient going to physical or

behavioral health therapy, or refuse to prescribe opioids
at all.
The expert faculty strongly recommended that primary care providers build a network of professionals
from other disciplines and community resources. It is not
enough to refer a patient to physical therapy; the provider and physical therapist should agree on goals and
communicate regularly about the patient’s progress. The
patient should experience treatment for chronic pain as a
team effort, while being a member of a team eases the
burden on the primary care provider to care for challenging and complex patients.
This study confirms that Project ECHO Chronic Pain
expert faculty made recommendations that aligned with
the CDC Guidelines for Prescribing Opioids [1]. Experts’
recommendations for treatment augment primary care
providers’ familiarity with their own patients and community resources, improving care for patients struggling
with chronic pain.
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clinic (9) and by a surgeon (3). These recommendations
were intended to complement or replace treatment with
opioids.
While working on the content analysis, the researchers
found it was often difficult to separate the psychosocial
issues from the more medical-specific recommendations.
The researchers agreed that 159 (40%) recommendations
included confounding psychosocial issues, most of which
involved behavioral health and the social determinants of
health. For example, 129 of the 159 recommendations
addressed the patient’s behavior, including engaging the
patient in self-care, personal goals, and behavioral health
treatment:

Thies et al.

